These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 17299196)

  • 21. Predicting long-term cardiovascular risk using the mayo clinic cardiovascular risk score in a referral population.
    Dhoble A; Lahr BD; Allison TG; Bailey KR; Thomas RJ; Lopez-Jimenez F; Kullo IJ; Gupta B; Kopecky SL
    Am J Cardiol; 2014 Sep; 114(5):704-10. PubMed ID: 25052544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Validation and generalizability of the predictive model of ischemic cardiovascular diseases in Chinese].
    Li X; Zhao LC; Li Y; Zhang LF; Zhou BF; Wu YF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Aug; 35(8):761-4. PubMed ID: 17963640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Brindle P
    Heart; 2008 Jan; 94(1):34-9. PubMed ID: 17916661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
    Albert MA; Glynn RJ; Buring J; Ridker PM
    Circulation; 2006 Dec; 114(24):2619-26. PubMed ID: 17116764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: data from the prospective Second Manifestations of ARTerial disease (SMART) cohort study.
    Sprengers RW; Janssen KJ; Moll FL; Verhaar MC; van der Graaf Y;
    J Vasc Surg; 2009 Dec; 50(6):1369-76. PubMed ID: 19837547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: the FRESCO Study.
    Marrugat J; Subirana I; Ramos R; Vila J; Marín-Ibañez A; Guembe MJ; Rigo F; Tormo Díaz MJ; Moreno-Iribas C; Cabré JJ; Segura A; Baena-Díez JM; de la Cámara AG; Lapetra J; Grau M; Quesada M; Medrano MJ; González Diego P; Frontera G; Gavrila D; Aicua EA; Basora J; García JM; García-Lareo M; Gutierrez JA; Mayoral E; Sala J; D'Agostino R; Elosua R;
    Prev Med; 2014 Apr; 61():66-74. PubMed ID: 24412897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of the Chronic Disease Population Risk Tool (CDPoRT) to Predict Incidence of Adult Chronic Disease.
    Ng R; Sutradhar R; Kornas K; Wodchis WP; Sarkar J; Fransoo R; Rosella LC
    JAMA Netw Open; 2020 Jun; 3(6):e204669. PubMed ID: 32496565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.
    Arts EE; Popa C; Den Broeder AA; Semb AG; Toms T; Kitas GD; van Riel PL; Fransen J
    Ann Rheum Dis; 2015 Apr; 74(4):668-74. PubMed ID: 24389293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery.
    Shahian DM; O'Brien SM; Filardo G; Ferraris VA; Haan CK; Rich JB; Normand SL; DeLong ER; Shewan CM; Dokholyan RS; Peterson ED; Edwards FH; Anderson RP;
    Ann Thorac Surg; 2009 Jul; 88(1 Suppl):S2-22. PubMed ID: 19559822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors.
    Carnethon MR; Gidding SS; Nehgme R; Sidney S; Jacobs DR; Liu K
    JAMA; 2003 Dec; 290(23):3092-100. PubMed ID: 14679272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study.
    Abdel-Qadir H; Thavendiranathan P; Austin PC; Lee DS; Amir E; Tu JV; Fung K; Anderson GM
    Eur Heart J; 2019 Dec; 40(48):3913-3920. PubMed ID: 31318428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.
    Pylypchuk R; Wells S; Kerr A; Poppe K; Riddell T; Harwood M; Exeter D; Mehta S; Grey C; Wu BP; Metcalf P; Warren J; Harrison J; Marshall R; Jackson R
    Lancet; 2018 May; 391(10133):1897-1907. PubMed ID: 29735391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
    Benn M; Nordestgaard BG; Jensen GB; Tybjaerg-Hansen A
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):661-70. PubMed ID: 17170368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a cardiovascular disease risk-prediction model using population health surveys: the Cardiovascular Disease Population Risk Tool (CVDPoRT).
    Manuel DG; Tuna M; Bennett C; Hennessy D; Rosella L; Sanmartin C; Tu JV; Perez R; Fisher S; Taljaard M
    CMAJ; 2018 Jul; 190(29):E871-E882. PubMed ID: 30037888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
    Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
    N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with 5-year risk of hip fracture in postmenopausal women.
    Robbins J; Aragaki AK; Kooperberg C; Watts N; Wactawski-Wende J; Jackson RD; LeBoff MS; Lewis CE; Chen Z; Stefanick ML; Cauley J
    JAMA; 2007 Nov; 298(20):2389-98. PubMed ID: 18042916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
    Bhatt DL; Eagle KA; Ohman EM; Hirsch AT; Goto S; Mahoney EM; Wilson PW; Alberts MJ; D'Agostino R; Liau CS; Mas JL; Röther J; Smith SC; Salette G; Contant CF; Massaro JM; Steg PG;
    JAMA; 2010 Sep; 304(12):1350-7. PubMed ID: 20805624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
    Zomer E; Liew D; Owen A; Magliano DJ; Ademi Z; Reid CM
    Eur J Prev Cardiol; 2014 Mar; 21(3):384-90. PubMed ID: 22588087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Framingham Heart Study risk equation predicts first cardiovascular event rates in New Zealanders at the population level.
    Milne R; Gamble G; Whitlock G; Jackson R
    N Z Med J; 2003 Nov; 116(1185):U662. PubMed ID: 14615804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.